Instrument overview

HCAHCA Healthcare

StockNYSEUnited StatesHealth careEU retail investors: available

+2.0% today · +6.7% over a year

No score: too little data.

Stability, Dividend safety: among the best of its peers; priced lower than most peers. Dividend yield 0.61%.

HCA Healthcare (HCA) belongs to the Health care sector and is listed on NYSE; country: United States. Its market value is about €94.2B. Over the past 12 months the price changed by +6.7%, with an annualised volatility of 33% and a largest fall of 34%. The dividend has not been lowered for 6 years.

Not scored: not enough data for a fair comparison.

Factor scores

How cheap the company is versus peers: earnings, cash flow, book value and sales relative to its price. More in the glossary →better than 70% of peers
Price trend over the last 12 and 6 months (excluding the last month) and distance from the 52-week high. More in the glossary →better than 32% of peers
Lower price swings, lower market sensitivity (beta) and shallower drawdowns score higher. More in the glossary →better than 93% of peers
0–100 points: payout versus earnings and cash flow, debt, cut history, years without a lower dividend and how stretched the yield looks. More in the glossary →better than 84% of peers

Percentiles within the peer group (100 = the best of its peers); dividend safety in points.

Main drivers

  • Share issuance (1 y)supports the score · better than 97% of peers
  • Volatility (1 y)supports the score · better than 87% of peers
  • Betasupports the score · better than 92% of peers

Red flags and notes

  • Negative equity Book equity is below zero.

Price chart

Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.

Key metrics

Valuation

P/E
15.6
P/S
1.3
Free-cash-flow yield
5.7%
Market cap (EUR)
€94.2B

Dividends

Dividend yield
0.61%
Payout ratio
10%
5-year dividend growth (per year)
12.4%
Years without a lower dividend
6

Returns and risk

1 day
+2.0%
1 month
+11.9%
1 year
+6.7%
Volatility, 1 yr
32.7%
Max drawdown, 1 yr
−33.6%
Beta
0.53

Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.

Similar companies

Same sector and region, closest in market value.

MRNAModerna Inc3/100.0%996.2%
CVSCVS Health Corporation9/103.1%11.2%
REGNRegeneron Pharmaceuticals10/100.4%40.6%
MCKMcKesson6/100.3%24.8%
ELVElevance Health10/101.6%34.2%
SYKStryker8/101.1%−7.5%
BMYBristol-Myers Squibb7/104.1%39.0%
MDTMedtronic9/102.8%15.2%

News and filings

What the marks mean
  • FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
  • Media reportA headline from a named media outlet. We link to it and do not check it.
  • RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.

Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.

Score changes in the last 12 months

Every published rating and change, logged when it was published (EU Market Abuse Regulation).

No published ratings in the last 12 months.